Contribution: National Strategy for Drugs for Rare Diseases Program
Government of Nunavut - Department of Health
$7,379,358.00
2425-HQ-000039
FY 2024-25 · 2025-03-07
Summary
To provide funding to willing jurisdictions to support improving access for patients with rare diseases to drugs for rare diseases, as well as improving and broadening rare disease treatments and services, to achieve better health outcomes.
Department
Program
National Strategy for Drugs for Rare Diseases ProgramNational Strategy for Drugs for Rare Diseases Program (linked with high confidence)
Location
Iqaluit, Nunavut, Canada
Recipient Type
Government
Business Number
877015826
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions
As published
Reference Number
271-2025-2026-Q1-00027
Amendment Number
1
Amendment Date
2025-05-02
Agreement Type
Contribution
Recipient Type
G
Recipient Business Number
877015826
Recipient Legal Name
Government of Nunavut - Department of Health
Recipient Country
CA
Recipient Province or Territory
NU
Recipient City
Iqaluit
Recipient Postal Code
X0A 0H0
Program Name
National Strategy for Drugs for Rare Diseases Program
Program Name (French)
Programme de la stratégie nationale sur les médicaments pour le traitement des maladies rares
Program Purpose
Canadian Health Systems and Programs
Program Purpose (French)
Systèmes et programmes de santé canadien
Agreement Title
2425-HQ-000039
Agreement Title (French)
2425-HQ-000039
Agreement Number
2425-HQ-000039
Agreement Value
$7,379,358.00
Agreement Start Date
2025-03-07
Agreement End Date
2027-03-31
Description
To provide funding to willing jurisdictions to support improving access for patients with rare diseases to drugs for rare diseases, as well as improving and broadening rare disease treatments and services, to achieve better health outcomes.
Description (French)
D'accorder des fonds aux provinces/territoires intéressés afin de favoriser l'accès aux médicaments pour le traitement des maladies rares par les patients atteints de maladies rares, de même qu’à améliorer et à élargir les traitements et services liés aux maladies rares, en vue d’obtenir de meilleurs résultats liés à la santé.
Expected Results
Improved collaboration across provincial/territorial drug plans related to drugs for rare decisions decision-making.
Canadians with rare diseases have better access to screening and diagnostic services they need.
Expected Results (French)
La collaboration à l'échelle des régimes d'assurance-médicaments des provinces/territoires est améliorée en ce qui concerne la prise de décisions liées aux médicaments pour le traitement des maladies rares.
Les Canadiens atteints de maladies rares bénéficient d’un meilleur accès aux services de dépistage et de diagnostic dont ils ont besoin.
Additional Information
The total agreement value previously disclosed has been updated to reflect a decrease resulting from this amendment.
Additional Information (French)
La valeur totale de l’entente précédemment divulguée a été mise à jour afin de refléter une diminution résultant de cette modification.
Organization Code
hc-sc
Organization
Health Canada | Santé Canada
